(Date:7/24/2008)... HR Consulting firm CPEhr, and Ju...d a Job Shadow Day for 30 high-students from Downt...d HR topics such as labor law, interviewing techni...les, Calif. (PRWEB) July 24, 2008 -- Los Angeles ... a non-profit organization, hosted a Job Shadow Da...
(Date:7/24/2008)... A cleanroom manufacturing compan...ule cleanrooms. The feature is a utility panel wh...d enhance the cleanroom appearance. , ...08 -- Gerbig Engineering, a designer, fabricator a... that they are now offering a utility panel for in...
(Date:7/24/2008)...ON, July 24 /PRNewswire-FirstCall/ --, Key Highli... of expectations and is now,raising targets for th...oup,revenues(1) of GBP492m up 6%, bringing Group o...ar. Misys is executing on its strategy and enterin...ding a platform for growth., To view the Multimed...
(Date:7/23/2008)... Ganey reports need for better physician-administr... nearly 28,000 physicians, SOUTH BEND, Ind., July...ospital Check-Up Report: Physician Perspectives on...be a gap in the physician-administration,relations...rs to be more,responsive to the ideas and needs of...
Breaking Medicine News(10 mins):Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Authoritative Report on Physician Perspectives Released Today 2...rganization (WHO) the leading cause of maternal de...//, Africa and Latin America. Statistics show tha...omplications and over half a million die every yea...s department of reproductive health and research s...
...ril issue of Radiology says that ultrasound is the...women and also assess// the effectiveness of chemo...Center in Houston have just finished a study where... been diagnosed as well as treated for breast canc...
...eveloped in the US are at an advanced stage but it...he public, says an expert involved in the project....rt. There are large numbers of people involved and...esting methods. We are on the way but it will be a...
...haracterised by extreme and irrational fear of sim...not know exactly what causes this. // To overcome...hich is still in the trial stage. The remedy deve... team contains a human hormone called cortisol, wh...
Other Medicine News:Health News:Ultrasound Can Detect Breast Cancer in Pregnant Women 2Health News:HIV Vaccine Field Trials In Advanced Stage 2(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Med...ing solutions for more than 20 years, has entered,...echnology to measure,regional oxygen saturation. T... is the continuous monitoring of the regional bloo... Early testing data and outcomes from an ongoing c...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 1MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 2The Glazier Group Removes Tomatoes from Menus Nationwide 21478 1The Glazier Group Removes Tomatoes from Menus Nationwide 21478 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 1Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 3Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 1Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 2...tudy results show,that elevated lipoprotein-associ...specific inflammatory enzyme associated with,unsta...e, is,especially predictive of heart disease risk ... medical condition that affects nearly,50 million ...rday,at the American College of Cardiology,s annua...
...leveland Clinic,researchers today report that the ...oprotein cholesterol (HDL) or the "good",cholester...of,plaque buildup in the coronary arteries as meas....D., Chairman of Cardiovascular Medicine at,Clevel...trial, will,present the study on Monday, March 26 ...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: